Application 211939
- Type
- NDA
- Sponsor
- ALVOGEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BONSITY | TERIPARATIDE | SOLUTION;SUBCUTANEOUS | 0.62MG/2.48ML (0.25MG/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |
| 47781-652 | teriparatide | teriparatide | Alvogen, Inc. | NDA | Current |